中文 | English
Return
Total: 12 , 1/2
Show Home Prev Next End page: GO
Author:(Ruo Qing ZHONG)

1.Chemical constituents of Poria cocos.

Peng-Fei YANG ; Chao LIU ; Hong-Qing WANG ; Jia-Chun LI ; Zhen-Zhong WANG ; Wei XIAO ; Ruo-Yun CHEN

China Journal of Chinese Materia Medica 2014;39(6):1030-1033

3.PDK1 plays a critical role in regulating cardiac function in mice and human.

Ruo-min DI ; Qiu-ting FENG ; Zai CHANG ; Qing LUAN ; Yang-yang ZHANG ; Jun HUANG ; Xin-Li LI ; Zhong-zhou YANG

Chinese Medical Journal 2010;123(17):2358-2363

4.In Vivo Assessment of Neurodegeneration in Type C Niemann-Pick Disease by IDEAL-IQ

Ruo Mi GUO ; Qing Ling LI ; Zhong Xing LUO ; Wen TANG ; Ju JIAO ; Jin WANG ; Zhuang KANG ; Shao Qiong CHEN ; Yong ZHANG

Korean Journal of Radiology 2018;19(1):93-100

5. Effect of Isopimpinellin on Expression of Inhibitory Neurotransmitter and Receptor Genes in Primary Hippocampal Neurons

Yu-meng HAO ; Ruo-yu WANG ; Qi-ming ZHONG ; Li-guo TONG ; Mei-qing SONG ; Qian YANG ; Ma-li FENG

Chinese Journal of Experimental Traditional Medical Formulae 2019;25(14):93-98

7.Discrimination of quality markers of Shujin Huoxue Capsules based on five principles coupled with cobweb model.

Ya ZHANG ; Jian-Fei TANG ; Qing-Hua TIAN ; Ruo-Yu CHEN ; Wei WANG ; Wen-Xia WANG ; Ji-Zhong YAN ; Hui ZHANG

China Journal of Chinese Materia Medica 2022;47(9):2440-2448

8.Risk factors for metabolic bone disease of prematurity in very/extremely low birth weight infants: a multicenter investigation in China.

Xiao-Ri HE ; Can LIANG ; Yuan-Qiang YU ; Pei-Jia WU ; Xiang-Hong CHEN ; Yu-Jun CHEN ; Cui-Qing LIU ; Xiang-Dong OU-YANG ; Ruo-Bing SHAN ; Wei-Wei PAN ; Yan-Mei CHANG ; Dan WANG ; Xiao-Yun ZHONG ; Kai-Ju LUO ; Yong-Hui YANG ; Qing-Yi DONG ; Jin-Tao HU ; Ming-Feng HE ; Xiao-Mei TONG ; Ping-Yang CHEN

Chinese Journal of Contemporary Pediatrics 2021;23(6):555-562

9.Antibacterial effect of low-temperature plasma on Enterococcus faecalis in dentinal tubules in vitro.

Ruo Qing ZHONG ; Meng Qian ZHU ; Ying Long LI ; Ji PAN

Journal of Peking University(Health Sciences) 2023;55(1):38-43

10.Secukinumab demonstrates high efficacy and a favorable safety profile over 52 weeks in Chinese patients with moderate to severe plaque psoriasis.

Lin CAI ; Jian-Zhong ZHANG ; Xu YAO ; Jun GU ; Quan-Zhong LIU ; Min ZHENG ; Shi-Fa ZHANG ; Jin-Hua XU ; Cheng-Xin LI ; Hao CHENG ; Qing GUO ; Wei-Li PAN ; Shen-Qiu LI ; Ruo-Yu LI ; Zai-Pei GUO ; Zhi-Qi SONG ; Shan-Shan LI ; Xiu-Qin DONG ; Linda WANG ; Rong FU ; Pascaline REGNAULT ; Pascal CHAREF ; Rafal MAZUR ; Manmath PATEKAR

Chinese Medical Journal 2020;133(22):2665-2673

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 12 , 1/2 Show Home Prev Next End page: GO